SUPPRESSIVE EFFECTS OF ANTIHISTAMINIC AND OR ANTI-PAF AGENTS ON PASSIVE ANAPHYLACTIC SHOCK IN MICE SENSITIZED WITH ALLOGENEIC MONOCLONAL IGE AND IGG(1) ANTIBODIES AND HYPERIMMUNE SERUM/
S. Kimura et al., SUPPRESSIVE EFFECTS OF ANTIHISTAMINIC AND OR ANTI-PAF AGENTS ON PASSIVE ANAPHYLACTIC SHOCK IN MICE SENSITIZED WITH ALLOGENEIC MONOCLONAL IGE AND IGG(1) ANTIBODIES AND HYPERIMMUNE SERUM/, Immunological investigations, 27(6), 1998, pp. 379-393
For the immunopharmacological characterization of murine passive anaph
ylactic shock, the effects of antihistaminics and/or anti-platelet-act
ivating factor (anti-PAF) agents were studied on the shock mediated by
allogeneic monoclonal IgE and IgG(1) antibodies and hyperimmune serum
. IgE antibody-mediated shock was strongly suppressed by cyproheptadin
e (10 mg/kg, ip) in every strain regardless of the age and sex of the
mice and the presence or absence of a shock potentiator. As far as tes
ted with CTS, DS, and B6D2F1 mice, IgE antibody-mediated shock was als
o suppressed by the other two antihistamines, triprolidine (10 mg/kg,
ip) and oxatomide (100 mg/kg, po). This type of shock was not suppress
ed by an anti-PAF agent, CV-6209 (3.3 mg/kg, iv), when tested on aged
CTS mice given no shock potentiator and young DS mice given a potentia
tor such as Bordetella pertussis organisms or DL-propranolol. IgG(1) a
ntibody-mediated shock was also suppressed by cyproheptadine in genera
l except for CTS mice. Suppression in the DL-propranolol-treated DS an
d C3H/He mice was not very marked on sensitization with undiluted or s
lightly diluted IgG1 ascites but quite striking on sensitization with
properly diluted ascites. In contrast with the effect of cyproheptadin
e, suppression by CV-6209 was obvious in aged CTS mice but not in youn
g DL-propranolol-treated DS mice. The shock. in DL-propranolol-treated
DS mice sensitized with undiluted or slightly diluted ascites was com
pletely abolished by the combined use of these two agents. These resul
ts suggest that histamine and/or PAF play a major role in IgE antibody
- and IgG(1) antibody-mediated shock. However, so far as tested in you
ng DS mice, the shock mediated by hyperimmune serum differed in drug s
usceptibility from that mediated by the monoclonal antibodies. In the
absence of shock. potentiators, prevention was produced by cyproheptad
ine in the males which had been sensitized with the 1:4 or 1:8 dilutio
n of the immune serum. In the presence of DL-propranolol, prevention w
as not produced even by the combined treatment with cyproheptadine and
CV-6209. Therefore, it is likely that some mediators other than hista
mine and PAF, whose release is triggered by antibody isotypes other th
an IgE and IgG(1), play a greater role for the shock mediated by hyper
immune serum than for the shock mediated by IgE or IgG1 antibody, espe
cially in the presence of shock potentiators.